paper-with-me

홈 › Papers

A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials

2023-09-25 · Alyssa M. Vanderbeek, Anna A. Vidovszky, Jessica L. Ross, Arman Sabbaghi, Jonathan R. Walsh, Charles K. Fisher, the Critical Path for Alzheimer's Disease, the Alzheimer's Disease Neuroimaging Initiative, the European Prevention of Alzheimer's Disease, Consortium, the Alzheimer's Disease Cooperative Study

A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analysis of a RCT. Training a generative AI algorithm on historical control data enables one to construct a digital twin generator (DTG) for RCT participants, which utilizes a participant's baseline covariates to generate a probability distribution for their potential control outcome. Summaries of the probability distribution from the DTG are highly predictive of the trial outcome, and adjusting for these features via regression can thus improve the quality of treatment effect inferences, while satisfying regulatory guidelines on statistical analyses, for a RCT. However, a critical assumption in this strategy is homoskedasticity, or constant variance of the outcome conditional on the covariates. In the case of heteroskedasticity, existing covariate adjustment methods yield inefficient estimators and underpowered tests. We propose to address heteroskedasticity via a weighted prognostic covariate adjustment methodology (Weighted PROCOVA) that adjusts for both the mean and variance of the regression model using information obtained from the DTG. We prove that our method yields unbiased treatment effect estimators, and demonstrate via comprehensive simulation studies and case studies from Alzheimer's disease that it can reduce the variance of the treatment effect estimator, maintain the Type I error rate, and increase the power of the test for the treatment effect from 80% to 85%~90% when the variances from the DTG can explain 5%~10% of the variation in the RCT participants' outcomes.

📄 PDF Abstract BibTeX arXiv:2309.14256

Code (0)

등록된 구현이 없습니다.

Tasks

regression

Similar Papers 제목 키워드 기반

Bayesian prognostic covariate adjustment

2020-12-24 · David Walsh, Alejandro Schuler, Diana Hall, Jon Walsh 외

Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency o…

DARTS: Targeting Prognostic Covariates in Budget-Constrained Sequential Experiments

2026-05-07 · Kateryna Husar, Alexander Volfovsky arxiv

Randomized controlled trials typically assume that prognostic covariates are known and available at no cost. In practice, obtaining high-dimensional pretreatment data is costly, forcing a trade-off between covariate-adap…

Causal Inference

Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score

2020-12-17 · Alejandro Schuler, David Walsh, Diana Hall, Jon Walsh 외

Estimating causal effects from randomized experiments is central to clinical research. Reducing the statistical uncertainty in these analyses is an important objective for statisticians. Registries, prior trials, and hea…

Bayesian Prognostic Covariate Adjustment With Additive Mixture Priors

2023-10-27 · Alyssa M. Vanderbeek, Arman Sabbaghi, Jon R. Walsh, Charles K. Fisher

Effective and rapid decision-making from randomized controlled trials (RCTs) requires unbiased and precise treatment effect inferences. Two strategies to address this requirement are to adjust for covariates that are hig…

Decision Making

Prognostic Covariate Adjustment for Logistic Regression in Randomized Controlled Trials

2024-02-29 · Yunfan Li, Arman Sabbaghi, Jonathan R. Walsh, Charles K. Fisher

Randomized controlled trials (RCTs) with binary primary endpoints introduce novel challenges for inferring the causal effects of treatments. The most significant challenge is non-collapsibility, in which the conditional …

regression